Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available katie8288Feb 90 min read
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec(AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients
This was an interesting update, especially seeing the latest information from the INVEST-HD Phase 3 trial. On a lighter note, when I have some free time, I’ve been playing Rocket Goal it’s a simple, fun way to relax for a few minutes.